Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FBGM9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,540
Award facts
- Contract value 100% obligated
- $33,539.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,539.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials. This non-set-aside delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 21, 2026. The award is a child contract executed under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical through December 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor and healthcare solutions provider within the federal medical procurement ecosystem, supplying a comprehensive range of brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains to military and veteran healthcare systems. The delivery order for Ozempic, a diabetes management medication, reflects the contractor's established capability to fulfill federal medical supply requirements through open competition and demonstrates the company's role in supporting the Defense Health Agency and other government healthcare institutions with essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26FBGM9?
SPE2DR26FBGM9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FBGM9 worth?
The government has obligated $33,540 on SPE2DR26FBGM9.
Is contract SPE2DR26FBGM9 an order under another contract?
Yes. SPE2DR26FBGM9 is a delivery order under SPE2DR25D2001, an indefinite delivery contract.
Was contract SPE2DR26FBGM9 competed?
The extent of competition for SPE2DR26FBGM9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award